[Use of cardioselective beta adrenergic blockaders in the treatment of circulatory failure].
D000083:Acetanilides / Q000494:pharmacology / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology / Q000627:therapeutic use*; D000368:Aged; D000605:Amino Alcohols / Q000494:pharmacology / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D005069:Evaluation Studies as Topic; D005260:Female; D006333:Heart Failure / Q000188:drug therapy*; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008875:Middle Aged; D011437:Propylamines / Q000494:pharmacology / Q000627:therapeutic use; D014693:Ventricular Fibrillation / Q000188:drug therapy
D000083:Acetanilides; D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D011437:Propylamines
Zachowanie sie kardioselektywnej blokady adrenergicznej beta w leczeniu niewydolności krazenia.